Professional Documents
Culture Documents
Acute Renal Failure
Acute Renal Failure
C2
Physiology Laboratory
Small Group Discussion
Output
March 9, 2016
EPIDEMIOLOGY
The definition of acute renal failure’s (ARF) epidemiology has been, and is
still, limited by the lack of studies evaluating ARF in the community setting, as well
as a lack of comparisons between intensive care unit (ICU) patients and non-ICU
patients. ARF is more common in the ICU and after cardiac surgery.
The incidence of ARF in critically ill patients has increased over the years, as
has the incidence of dialysis-requiring ARF, especially among the elderly, the male
gender, and the black population Overall, mortality has declined for the critically ill,
but the reverse has occurred for ARF patients who need dialysis.
The typical ARF patient is more complex clinically than they were 30 years
ago, and is also more complex than the non-ARF patient; ARF tends to affect people
of older age, who tend to have a higher rate of comorbidities and a greater likelihood
of developing severe disease, multiple organ failure, and sepsis. The leading cause
of ARF is sepsis, followed by nephrotoxin use and ischemia. Septic ARF can be
considered a separate clinical entity from non-septic ARF. Septic ARF patients are
less likely to have pre-existing renal dysfunction and be dependent on dialysis at
discharge, but their disease burden is greater and they are more prone to
concomitant non-renal dysfunction, require mechanically assisted ventilation and
vasoactive drugs, are prone to longer hospital stays, and their probability ofdying is
higher during their stay in hospital. Given the growing incidence of ARF and
consequent increased healthcare burden, measures to prevent ARF have been
sought. Some interventions may help reduce mortality in patients with or at risk of
ARF, such as perioperative hemodynamic optimization, albumin in cirrhotic patients,
spontaneous bacterial peritonitis, and terlipressin for Type 1 hepatorenal syndrome.
In contrast, positive fluid balance, hydroxyethyl starch, and loop diuretics may
have deleterious effects in patients with or at risk of ARF. Unfortunately, prediction of
the risk of ARF is difficult or even impossible in many situations today, which limits
prophylactic action.
CAUSES
Diseases and conditions that may slow blood flow to the kidneys and lead to kidney
failure include:
These diseases, conditions and agents may damage the kidneys and lead to acute
kidney failure:
Blood clots in the veins and arteries in and around the kidneys
Cholesterol deposits that block blood flow in the kidneys
Glomerulonephritis (gloe-mer-u-loe-nuh-FRY-tis), inflammation of the tiny filters in
the kidneys (glomeruli)
Hemolytic uremic syndrome, a condition that results from premature destruction
of red blood cells
Infection
Lupus, an immune system disorder causing glomerulonephritis
Medications, such as certain chemotherapy drugs, antibiotics, dyes used during
imaging tests and zoledronic acid (Reclast, Zometa), used to treat osteoporosis
and high blood calcium levels (hypercalcemia)
Multiple myeloma, a cancer of the plasma cells
Scleroderma, a group of rare diseases affecting the skin and connective tissues
Thrombotic thrombocytopenic purpura, a rare blood disorder
Toxins, such as alcohol, heavy metals and cocaine
Vasculitis, an inflammation of blood vessels
Diseases and conditions that block the passage of urine out of the body (urinary
obstructions) and can lead to acute kidney failure include:
Bladder cancer
Blood clots in the urinary tract
Cervical cancer
Colon cancer
Enlarged prostate
Kidney stones
Nerve damage involving the nerves that control the bladder
Prostate cancer
PATHOPHYSIOLOGY
Postrenal ARF, caused by obstruction of the urinary tract, accounted for 10%
of cases in the Madrid study.2 Urinary tract obstructions may be within the urinary
tract (e.g., blood clots, stones, sloughed papillae, fungus balls), or extrinsic (e.g.,
tumors, retroperitoneal fibrosis, even inadvertent ligation).
Once prerenal and postrenal causes are ruled out, intrinsic renal failure is
likely. Intrinsic ARF, caused by disease of the renal parenchyma, accounted for 69%
of cases in the Madrid study.2 Acute tubular necrosis (ATN), the most common type
of intrinsic ARF, accounted for 45% of all cases of ARF. Most of the following
discussion is therefore focused on ATN; other types of intrinsic ARF have been
reviewed in detail in studies by Glassock and colleagues.3
ATN is most often caused by renal hypoperfusion and renal ischemia. Other
causes include various endogenous nephrotoxic substances (e.g., myoglobin and
hemoglobin after trauma; cellular products in tumor lysis syndrome; crystals of uric
acid, calcium, or oxalate) and a host of exogenous substances . If a patient develops
ATN while receiving medications, each medication must be reviewed for the
possibility of nephrotoxicity.
In oliguric ATN, renal plasma flow declines, but the glomerular filtration rate
declines even more. This dichotomy suggests that constriction of the afferent
arterioles contributes to the pathophysiologic process. Ischemic injury to epithelial
The distribution of tubular necrosis in the kidneys is patchy, and the degree of
necrosis does not correlate with the level of renal dysfunction. This is because the
medulla of the kidneys, containing the thick ascending limbs of Henle, is less well
vascularized and perfused than the cortex and therefore is disproportionately
affected by ischemia. The ischemic insult in this region is worsened by reperfusion
injury. Persistent vasoconstriction and congestion from white cells and cell debris
lead to ongoing hypoxia and necrosis.
DIAGNOSIS
Blood tests. Kidney function tests look for the level of waste products, such
as creatinine and urea, in your blood.
Urine tests. Analyzing a sample of your urine may reveal abnormalities that
point to chronic kidney failure and help identify the cause of chronic kidney
disease.
Imaging tests. Your doctor may use ultrasound to assess your kidneys'
structure and size. Other imaging tests may be used in some cases.
Removing a sample of kidney tissue for testing. Your doctor may
recommend a kidney biopsy to remove a sample of kidney tissue. Kidney
biopsy is often done with local anesthesia using a long, thin needle that's
inserted through your skin and into your kidney. The biopsy sample is sent to
a lab for testing to help determine what's causing your kidney problem.
buffering
Hypocalcemia
Coagulopathies
Increased
vascular Edema
volume Acidosis
Uremia
Hyperparathyroidism
Heart
Pericarditis
failure
Table 1
Treatment for acute kidney failure typically requires a hospital stay. Most
people with acute kidney failure are already hospitalized. How long you'll stay in the
hospital depends on the reason for your acute kidney failure and how quickly your
kidneys recover.
Treatment for acute kidney failure involves identifying the illness or injury that
originally damaged your kidneys. Your treatment options depend on what's causing
your kidney failure.Treating complications until your kidneys recover
Your doctor will also work to prevent complications and allow your kidneys time to
heal. Treatments that help prevent complications include:
Choose lower potassium foods. Your dietitian may recommend that you
choose lower potassium foods. High-potassium foods include bananas,
Prevention
References:
2. Koeppen, BM; Stanton, BA: Berne and Levy Physiology, 6 th edition. Elsevier
Inc. 2010.
3. en.wikipedia.org
4.http://www.mayoclinic.org/diseases-conditions/kidneyfailure/basics/prevention/
con-20024029
Physiology Laboratory Small Group Discussion Output | Acute Renal Failure 9